Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$6.81 - $136.4 $306 - $6,138
-45 Reduced 16.85%
222 $2,000
Q2 2022

Aug 10, 2022

SELL
$5.16 - $11.95 $743 - $1,720
-144 Reduced 35.04%
267 $2,000
Q1 2022

May 12, 2022

SELL
$6.57 - $12.0 $7,522 - $13,740
-1,145 Reduced 73.59%
411 $2,000
Q4 2021

Feb 10, 2022

BUY
$10.73 - $23.74 $14,635 - $32,381
1,364 Added 710.42%
1,556 $17,000
Q3 2021

Nov 10, 2021

BUY
$13.65 - $22.4 $2,620 - $4,300
192 New
192 $4,000

Others Institutions Holding PRTG

About PORTAGE BIOTECH INC.


  • Ticker PRTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,943,700
  • Market Cap $68.5M
  • Description
  • Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...
More about PRTG
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.